More Phase 3 Data Support Abrocitinib for Atopic Dermatitis More Phase 3 Data Support Abrocitinib for Atopic Dermatitis

Abrocitinib is safe and effective for adolescents and adults with moderate to severe atopic dermatitis, results from a phase 3 study show.Medscape Medical News

Source: Medscape Medical News Headlines - June 24, 2020 Category: Consumer Health News Tags: Dermatology News Source Type: news